Definitive Contract W81XWH16C0127
Award Date 8/29/16
Potential Completion Date 8/28/19
Potential Value $3.2M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Redwood City, CA 94063, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase III Action
Primary Consortia Member
Not listed Similar Awards
- This is a Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Emergent Travel Health Inc., a small business prime contractor. The $1,000,000.00 SBIR Phase II contract was awarded on September 21, 2015 for a Small Business Technology Transfer (STTR) research project. The contract supports the development of an infectious disease vaccine, with work being performed at the contractor's facility in Redwood City, California. Emergent Travel Health Inc. has previously provided...
- This is a Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Emergent Travel Health Inc., a for-profit biopharmaceutical company, for $111,369.51. The contract is for Phase III of a Small Business Innovation Research (SBIR) program action, with an ultimate completion date of April 27, 2016. Emergent Travel Health Inc. has previously provided vaccine stability testing, vaccine development, and vaccine procurement services to federal agencies including the National Institutes...
- This federal contract award is for SBIR Phase III research under Topic A14-045 "Modernized Production Adenovirus Vaccine (MPAV)" for the Department of the Army Medical Command. The prime contractor is Emergent Travel Health Inc., a for-profit biopharmaceutical company that specializes in vaccine development and production. The contract is a definitive, cost-no-fee contract with a potential value of $652,166.39. The work is being performed at Emergent's facility in Redwood City,...
- The Biomedical Advanced Research and Development Authority (BARDA), operating under the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response, awarded a definitive firm fixed price contract to Emergent Product Development Gaithersburg Inc. valued at approximately $1.53 billion. This no-cost modification updates contract articles for the development of medical countermeasures targeting filovirus outbreaks, which are identified as critical...
- This is a $19,763,563.00 cost-plus-fixed-fee delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Emergent Manufacturing Operations Baltimore LLC, a for-profit limited liability company and manufacturer of goods registered in the System for Award Management (SAM). The contract is part of the Centers for Innovation in Advanced...
- The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response awarded a $1.43 billion cost-plus-fixed-fee definitive contract to Emergent Product Development Gaithersburg Inc. on September 30, 2016, for the development and production of the EO14042 Emergent AV7909 anthrax vaccine. The contract, which carries no set-aside designation, is scheduled for completion by September 29, 2026, with performance taking place at the contractor's...
- This is a $5,356,859.28 federal contract awarded by the Defense Health Agency to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), a non-profit organization. The contract is for the development of a bovine immunoglobulin (BIgG) supplement to prevent traveler's diarrhea caused by Enterotoxigenic E. coli (ETEC). The contract includes several subcontractors to support the overall effort, including The Emmes Company LLC for data management and clinical...
- This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the U.S. Department of Health and Human Services, to Profectus Biosciences, Inc., a small business contractor. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, with a ceiling value of $7,524,330.27 and a period of performance through November 30, 2016. The contract is for the GMP (Good Manufacturing Practice) manufacture of the...
- This definitive contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Emergent BioSolutions Canada Inc., a for-profit organization, is valued at $26,553,434.00. The contract is for the supply of VIGIV, a medical countermeasure against chemical, biological, radiological, and nuclear threats. As a prime contractor, Emergent BioSolutions has received over $770 million in federal contracts from agencies like the Defense Logistics...
- <p>This is a $1,999,175.53 firm fixed-price Definitive Contract awarded by the Defense Health Agency (DHA), a defense agency, to Technovax Inc., a small disadvantaged business, under the SBIR (Small Business Innovation Research) Phase II program. The contract is for research and development work, with a period of performance ending on February 16, 2021. The contract was set aside for small businesses.</p>